ORIGINAL RESEARCH
Published on 20 Oct 2025
Cost-effectiveness of iruplinalkib versus crizotinib in first-line anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer patients in China
doi 10.3389/fphar.2025.1651463
- 815 views
899
Total downloads
6,472
Total views and downloads
Submit your idea
You will be redirected to our submission process.
ORIGINAL RESEARCH
Published on 20 Oct 2025
SYSTEMATIC REVIEW
Published on 25 Jul 2025
OPINION
Published on 03 Jul 2025
ORIGINAL RESEARCH
Published on 02 Jun 2025
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.